Literature DB >> 17582852

Rituxan warning.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17582852

Source DB:  PubMed          Journal:  FDA Consum        ISSN： 0362-1332


× No keyword cloud information.
  11 in total

1.  Immune agents for the treatment of Devic's neuromyelitis optica.

Authors:  R Bergamaschi
Journal:  Neurol Sci       Date:  2007-10       Impact factor: 3.307

Review 2.  Neurologic complications of antitumor antibody therapies.

Authors:  Teri N Kreisl
Journal:  Curr Neurol Neurosci Rep       Date:  2008-05       Impact factor: 5.081

Review 3.  Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders.

Authors:  M C Levesque
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 4.  [Targeting B cells in multiple sclerosis. Current concepts and strategies].

Authors:  T Menge; H-C Büdingen; M C Dalakas; B C Kieseier; H-P Hartung
Journal:  Nervenarzt       Date:  2009-02       Impact factor: 1.214

Review 5.  Rituximab therapy for membranous nephropathy: a systematic review.

Authors:  Andrew S Bomback; Vimal K Derebail; Julie G McGregor; Abhijit V Kshirsagar; Ronald J Falk; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-11       Impact factor: 8.237

6.  Progressive multifocal leukoencephalopathy.

Authors:  Allen J Aksamit
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.598

Review 7.  Disease-modifying agents for multiple sclerosis: recent advances and future prospects.

Authors:  Til Menge; Martin S Weber; Bernhard Hemmer; Bernd C Kieseier; Hans-Christian von Büdingen; Clemens Warnke; Scott S Zamvil; Aaron Boster; Omar Khan; Hans-Peter Hartung; Olaf Stüve
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Biological therapy in systemic lupus erythematosus.

Authors:  Mariana Postal; Lilian Tl Costallat; Simone Appenzeller
Journal:  Int J Rheumatol       Date:  2012-01-30

9.  Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.

Authors:  Matthew L Stoll; Alisa C Gotte
Journal:  Biologics       Date:  2008-06

10.  Neuromyelitis optica.

Authors:  Dean M Wingerchuk; Brian G Weinshenker
Journal:  Curr Treat Options Neurol       Date:  2008-01       Impact factor: 3.972
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.